PBMs help insurers streamline drug management and may help negotiate lower drug costs with manufacturers. However, they may also profit from setting prices and controlling pharmacy networks, making ...

Bipartisan legislative momentum and expanding litigation are accelerating PBM-focused reform at federal and state levels, ...

As regulatory pressure and rising drug costs reshape expectations for pharmacy benefit managers (PBMs), real-time data is becoming central to how PBMs build trust and retain clients. Payers are facing ...

Early 2026 marks a coordinated turning point in the federal regulation and oversight of pharmacy benefit managers (PBMs), and these new PBM rules have significant fiduciary implications for ERISA ...

For over a decade, pharmacy benefit managers have been in the hot seat, absorbing the bulk of Washington’s bipartisan scrutiny over rising prescription drug costs. Now, the pricing pendulum is ...

Pharmacy benefit manager (PBM) reform has been an active and evolving area for policymakers in Washington, D.C. for many years but reform efforts have noticeably picked up pace in 2026. Recent actions ...